MIKE ONEILL

2.5K posts

MIKE ONEILL

MIKE ONEILL

@bioquicknews

Editor & Publisher, BioQuick News

Madison, Wisconsin Katılım Haziran 2009
1.6K Takip Edilen353 Takipçiler
MIKE ONEILL
MIKE ONEILL@bioquicknews·
Moderna & Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA® (Pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial in Stage III/IVMelanoma; Resul…lnkd.in/gfF827Nn lnkd.in/gYczG99Z
English
0
0
0
0
MIKE ONEILL
MIKE ONEILL@bioquicknews·
Moderna & Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA® (Pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial in Stage III/IVMelanoma; Resul…lnkd.in/gG-uvfYQ lnkd.in/gYczG99Z
English
0
0
0
0